Abstract
Tetanus is an acute, severe infection caused by a neurotoxin secreting bacterium. Various prognostic factors affecting mortality in tetanus patients have been described in the literature. In this study, we aimed to analyze the factors affecting mortality in hospitalized tetanus patients in a large case series. This retrospective multicenter study pooled data of tetanus patients from 25 medical centers. The hospitals participating in this study were the collaborating centers of the Infectious Diseases International Research Initiative (ID-IRI). Only adult patients over the age of 15 years with tetanus were included. The diagnosis of tetanus was made by the clinicians at the participant centers. Izmir Bozyaka Education and Research Hospital’s Review Board approved the study. Prognostic factors were analyzed by using the multivariate regression analysis method. In this study, 117 adult patients with tetanus were included. Of these, 79 (67.5%) patients survived and 38 (32.5%) patients died. Most of the deaths were observed in patients >60 years of age (60.5%). Generalized type of tetanus, presence of pain at the wound area, presence of generalized spasms, leukocytosis, high alanine aminotransferase (ALT) and C-reactive protein (CRP) values on admission, and the use of equine immunoglobulins in the treatment were found to be statistically associated with mortality (p < 0.05 for all). Here, we describe the prognostic factors for mortality in tetanus. Immunization seems to be the most critical point, considering the advanced age of our patients. A combination of laboratory and clinical parameters indicates mortality. Moreover, human immunoglobulins should be preferred over equine sera to increase survival.
Similar content being viewed by others
References
Hodowanec A, Bleck TP (2015) Tetanus (Clostridium tetani). In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Elsevier Co, Philadelphia, pp 2757–2762
Erdem H, Inan A, Altındis S, Carevic B, Askarian M, Cottle L, Beovic B, Csomos A, Metodiev K, Ahmetagic S, Harxhi A, Raka L, Grozdanovski K, Nechifor M, Alp E, Bozkurt F, Hosoglu S, Balik I, Yilmaz G, Jereb M, Moradi F, Petrov N, Kaya S, Koksal I, Aslan T, Elaldi N, Akkoyunlu Y, Moravveji SA, Csato G, Szedlak B, Akata F, Oncu S, Grgic S, Cosic G, Stefanov C, Farrokhnia M, Müller M, Luca C, Koluder N, Korten V, Platikanov V, Ivanova P, Soltanipour S, Vakili M, Farahangiz S, Afkhamzadeh A, Beeching N, Ahmed SS, Cami A, Shiraly R, Jazbec A, Mirkovic T, Leblebicioglu H, Naber K (2014) Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran—a prospective multicenter point prevalence study. J Infect 68(2):131–140
Erdem H, Tekin-Koruk S, Koruk I, Tozlu-Keten D, Ulu-Kilic A, Oncul O, Guner R, Birengel S, Mert G, Nayman-Alpat S, Eren-Tulek N, Demirdal T, Elaldi N, Ataman-Hatipoglu C, Yilmaz E, Mete B, Kurtaran B, Ceran N, Karabay O, Inan D, Cengiz M, Sacar S, Yucesoy-Dede B, Yilmaz S, Agalar C, Bayindir Y, Alpay Y, Tosun S, Yilmaz H, Bodur H, Erdem HA, Dikici N, Dizbay M, Oncu S, Sezak N, Sari T, Sipahi OR, Uysal S, Yeniiz E, Kaya S, Ulcay A, Kurt H, Besirbellioglu BA, Vahaboglu H, Tasova Y, Usluer G, Arman D, Diktas H, Ulusoy S, Leblebicioglu H (2011) Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs. Ann Clin Microbiol Antimicrob 10:38
Erdem H, Stahl JP, Inan A, Kilic S, Akova M, Rioux C, Pierre I, Canestri A, Haustraete E, Engin DO, Parlak E, Argemi X, Bruley D, Alp E, Greffe S, Hosoglu S, Patrat-Delon S, Heper Y, Tasbakan M, Corbin V, Hopoglu M, Balkan II, Mutlu B, Demonchy E, Yilmaz H, Fourcade C, Toko-Tchuindzie L, Kaya S, Engin A, Yalci A, Bernigaud C, Vahaboglu H, Curlier E, Akduman D, Barrelet A, Oncu S, Korten V, Usluer G, Turgut H, Sener A, Evirgen O, Elaldi N, Gorenek L (2014) The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study. Eur J Clin Microbiol Infect Dis 33(9):1591–1599
Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee (2006) Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 55(RR-17):1–37
Centers for Disease Control and Prevention (CDC) (2012) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 61(25):468–470
Ajose FO, Odusanya OO (2009) Survival from adult tetanus in Lagos, Nigeria. Trop Doct 39(1):39–40
Bandele EO, Akinyanju OO, Bojuwoye BJ (1991) An analysis of tetanus deaths in Lagos. J Natl Med Assoc 83(1):55–58
Anuradha S (2006) Tetanus in adults—a continuing problem: an analysis of 217 patients over 3 years from Delhi, India, with special emphasis on predictors of mortality. Med J Malaysia 61(1):7–14
Sanya EO, Taiwo SS, Olarinoye JK, Aje A, Daramola OO, Ogunniyi A (2007) A 12-year review of cases of adult tetanus managed at the University College Hospital, Ibadan, Nigeria. Trop Doct 37(3):170–173
Chukwubike OA, God’spower AE (2009) A 10-year review of outcome of management of tetanus in adults at a Nigerian tertiary hospital. Ann Afr Med 8(3):168–172
Ramos JM, Reyes F, Tesfamariam A (2008) Tetanus in a rural Ethiopian hospital. Trop Doct 38(2):104–105
An VT, Khue PM, Yen LM, Phong ND, Strobel M (2015) Tetanus in Ho Chi Minh City, Vietnam: epidemiological, clinical and outcome features of 389 cases at the Hospital for Tropical Diseases. Bull Soc Pathol Exot 108(5):342–348
Arogundade FA, Bello IS, Kuteyi EA, Akinsola A (2004) Patterns of presentation and mortality in tetanus: a 10-year retrospective review. Niger Postgrad Med J 11(3):198–202
Isono H, Miyagami T, Katayama K, Isono M, Hasegawa R, Gomi H, Kobayashi H (2016) Tetanus in the elderly: the management of intensive care and prolonged hospitalization. Intern Med 55(22):3399–3402
Tanriover MD, Soyler C, Ascioglu S, Cankurtaran M, Unal S (2014) Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. Eur J Intern Med 25(6):528–532
Simonsen O, Badsberg JH, Kjeldsen K, Møller-Madsen B, Heron I (1986) The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C 94(2):77–82
Edsall G (1976) Editorial: The inexcusable disease. JAMA 235(1):62–63
Livorsi DJ, Eaton M, Glass J (2010) Generalized tetanus despite prior vaccination and a protective level of anti-tetanus antibodies. Am J Med Sci 339(2):200–201
Cooke MW (2009) Are current UK tetanus prophylaxis procedures for wound management optimal? Emerg Med J 26(12):845–848
Hanif H, Anjum A, Ali N, Jamal A, Imran M, Ahmad B, Ali MI (2015) Isolation and antibiogram of clostridium tetani from clinically diagnosed tetanus patients. Am J Trop Med Hyg 93(4):752–756
Campbell JI, Lam TM, Huynh TL, To SD, Tran TT, Nguyen VM, Le TS, Nguyen VV, Parry C, Farrar JJ, Tran TH, Baker S (2009) Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg 80(5):827–831
Ahmadsyah I, Salim A (1985) Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed) 291(6496):648–650
European Centre for Disease Prevention and Control (ECDC) (2013) Annual epidemiological report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. ECDC, Stockholm. Available online at: http://ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf. Accessed 4 Sep 2013
Tejpratap SP, Tiwari MD (2008) Tetanus. In: Roush SW, Baldy LM (eds) Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention (CDC), Atlanta. Available online at: https://www.cdc.gov/vaccines/pubs/surv-manual/index.html. Accessed 22 Feb 2017
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
We did not receive any kind of funding.
Conflict of interest
None to declare.
Ethical approval
Yes, it is obtained from Izmir Bozyaka Education and Research Hospital’s Review Board.
Informed consent
Not applicable. The study has a retrospective design.
Rights and permissions
About this article
Cite this article
Tosun, S., Batirel, A., Oluk, A.I. et al. Tetanus in adults: results of the multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 36, 1455–1462 (2017). https://doi.org/10.1007/s10096-017-2954-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-017-2954-3